Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.22.0.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue, Major Customer [Line Items]    
Revenues $ 14,135,132 $ 14,616,989
FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 14,135,132 13,754,158
PREBOOST Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues   862,831
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 11,574,266 9,101,739
Global Public Health Sector [Member] | FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues $ 2,560,866 $ 4,652,419